University of Nebraska Medical Center Remdesivir Clinical Trial Shows Accelerated Recovery From Advanced COVID-19
April 30, 2020
April 30, 2020
OMAHA, Nebraska, April 30 -- The University of Nebraska Medical Center issued the following news release:
Hospitalized patients with advanced COVID-19 and lung involvement who received remdesivir recovered faster than similar patients who received placebo, according to a preliminary data analysis from a randomized, controlled trial involving 1,063 patients, which began on Feb. 21.
The trial (known as the Adaptive COVID-19 Treatment Trial, or ACTT), sponsored by the Nati . . .
Hospitalized patients with advanced COVID-19 and lung involvement who received remdesivir recovered faster than similar patients who received placebo, according to a preliminary data analysis from a randomized, controlled trial involving 1,063 patients, which began on Feb. 21.
The trial (known as the Adaptive COVID-19 Treatment Trial, or ACTT), sponsored by the Nati . . .